Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Pomerantz, RJ
   Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication
   CLINICAL INFECTIOUS DISEASES
   
   R.J. Pomerantz, "Reservoirs of human immunodeficiency virus type 1: The main obstacles to viral eradication", CLIN INF D, 34(1), 2002, pp. 91-97
2. Carey, KD; Stork, PJS
   Nonisotopic methods for detecting activation of small G proteins
   G PROTEIN PATHWAYS: PT C, EFFECTOR MECHANISMS
   
   K.D. Carey e P.J.S. Stork, "Nonisotopic methods for detecting activation of small G proteins", METH ENZYM, 345, 2002, pp. 383-397
3. Doruker, P; Bahar, I; Baysal, C; Erman, B
   Collective deformations in proteins determined by a mode analysis of molecular dynamics trajectories
   POLYMER
   
   P. Doruker et al., "Collective deformations in proteins determined by a mode analysis of molecular dynamics trajectories", POLYMER, 43(2), 2002, pp. 431-439
4. Foley, HD; Otero, M; Orenstein, JM; Pomerantz, RJ; Schnell, MJ
   Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1)envelopes display HIV-1-like tropism and target human dendritic cells
   JOURNAL OF VIROLOGY
   
   H.D. Foley et al., "Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1)envelopes display HIV-1-like tropism and target human dendritic cells", J VIROLOGY, 76(1), 2002, pp. 19-31
5. Kattan, M; Platzker, A; Mellins, RB; Schluchter, MD; Chen, XC; Peavy, H; Steinbach, S; Wohl, ME; Hiatt, P; Hunter, J; Colin, AA
   Respiratory diseases in the first year of life in children born to HIV-1-infected women
   PEDIATRIC PULMONOLOGY
   
   M. Kattan et al., "Respiratory diseases in the first year of life in children born to HIV-1-infected women", PEDIAT PULM, 31(4), 2001, pp. 267-276
6. Bertalot, G; Villanacci, V; Gramegna, M; Orvieto, E; Negrini, R; Saleri, A; Terraroli, C; Ravelli, R; Cestari, R; Viale, G
   Evidence of Epstein-Barr virus infection in ulcerative colitis
   DIGESTIVE AND LIVER DISEASE
   
   G. Bertalot et al., "Evidence of Epstein-Barr virus infection in ulcerative colitis", DIG LIVER D, 33(7), 2001, pp. 551-558
7. Romero-Rojas, A; Ponce-Hernandez, C; Mendoza, SE; Reyes-Esparza, JA; Estrada-Parra, S; Hadden, JW
   Immunomodulatory properties of Mycoplasma pulmonis. II. Studies on the mechanisms of immunomodulation
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   A. Romero-Rojas et al., "Immunomodulatory properties of Mycoplasma pulmonis. II. Studies on the mechanisms of immunomodulation", INT IMMUNO, 1(9-10), 2001, pp. 1689-1697
8. Tran, GT; Carter, N; Hodgkinson, SJ
   Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   G.T. Tran et al., "Mycophenolate mofetil treatment accelerates recovery from experimental allergic encephalomyelitis", INT IMMUNO, 1(9-10), 2001, pp. 1709-1723
9. Trobonjaca, Z; Radosevic-Stasic, B; Crncevic, Z; Rukavina, D
   Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes
   INTERNATIONAL IMMUNOPHARMACOLOGY
   
   Z. Trobonjaca et al., "Modulatory effects of octreotide on anti-CD3 and dexamethasone-induced apoptosis of murine thymocytes", INT IMMUNO, 1(9-10), 2001, pp. 1753-1764
10. Ross, R; Reske-Kunz, AB
    The role of NO in contact hypersensitivity
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    R. Ross e A.B. Reske-Kunz, "The role of NO in contact hypersensitivity", INT IMMUNO, 1(8), 2001, pp. 1469-1478
11. Cho, YK; Sung, H; Lee, HJ; Joo, CH; Cho, GJ
    Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    Y.K. Cho et al., "Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed", INT IMMUNO, 1(7), 2001, pp. 1295-1305
12. Oka, H; Emori, Y; Kobayashi, N; Hayashi, Y; Nomoto, K
    Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses
    INTERNATIONAL IMMUNOPHARMACOLOGY
    
    H. Oka et al., "Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses", INT IMMUNO, 1(3), 2001, pp. 521-532
13. Verhasselt, V; Goldman, M
    New concepts on the pathogenesis of autoimmune disease
    ISRAEL MEDICAL ASSOCIATION JOURNAL
    
    V. Verhasselt e M. Goldman, "New concepts on the pathogenesis of autoimmune disease", ISR MED ASS, 3(8), 2001, pp. 599-602
14. Cooke, A; Phillips, JM; Parish, NM
    Tolerogenic strategies to halt or prevent type I diabetes
    NATURE IMMUNOLOGY
    
    A. Cooke et al., "Tolerogenic strategies to halt or prevent type I diabetes", NAT IMMUNOL, 2(9), 2001, pp. 810-815
15. Akbari, O; DeKruyff, RH; Umetsu, DT
    Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
    NATURE IMMUNOLOGY
    
    O. Akbari et al., "Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen", NAT IMMUNOL, 2(8), 2001, pp. 725-731
16. Sperling, AI; Bluestone, JA
    ICOS costimulation: it's not just for T(H)2 cells anymore
    NATURE IMMUNOLOGY
    
    A.I. Sperling e J.A. Bluestone, "ICOS costimulation: it's not just for T(H)2 cells anymore", NAT IMMUNOL, 2(7), 2001, pp. 573-574
17. Liu, YJ; Kanzler, H; Soumelis, V; Gilliet, M
    Dendritic cell lineage, plasticity and cross-regulation
    NATURE IMMUNOLOGY
    
    Y.J. Liu et al., "Dendritic cell lineage, plasticity and cross-regulation", NAT IMMUNOL, 2(7), 2001, pp. 585-589
18. Camacho, SA; Heath, WR; Carbone, FR; Sarvetnick, N; LeBon, A; Karlsson, L; Peterson, PA; Webb, SR
    A key role for ICAM-I in generating effector cells mediating inflammatory responses
    NATURE IMMUNOLOGY
    
    S.A. Camacho et al., "A key role for ICAM-I in generating effector cells mediating inflammatory responses", NAT IMMUNOL, 2(6), 2001, pp. 523-529
19. Rothenberg, EV
    Notchless T cell maturation?
    NATURE IMMUNOLOGY
    
    E.V. Rothenberg, "Notchless T cell maturation?", NAT IMMUNOL, 2(3), 2001, pp. 189-190
20. Latchman, Y; Wood, CR; Chernova, T; Chaudhary, D; Borde, M; Chernova, I; Iwai, Y; Long, AJ; Brown, JA; Nunes, R; Greenfield, EA; Bourque, K; Boussiotis, VA; Carter, LL; Carreno, BM; Malenkovich, N; Nishimura, H; Okazaki, T; Honjo, T; Sharpe, AH; Freeman, GJ
    PD-L2 is a second ligand for PD-I and inhibits T cell activation
    NATURE IMMUNOLOGY
    
    Y. Latchman et al., "PD-L2 is a second ligand for PD-I and inhibits T cell activation", NAT IMMUNOL, 2(3), 2001, pp. 261-268
21. Yang, JF; Zhu, H; Murphy, TL; Ouyang, WJ; Murphy, KM
    IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production
    NATURE IMMUNOLOGY
    
    J.F. Yang et al., "IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production", NAT IMMUNOL, 2(2), 2001, pp. 157-164
22. McIntire, JJ; Umetsu, SE; Akbari, O; Potter, M; Kuchroo, VK; Barsh, GS; Freeman, GJ; Umetsu, DT; DeKruyff, RH
    Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family
    NATURE IMMUNOLOGY
    
    J.J. McIntire et al., "Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family", NAT IMMUNOL, 2(12), 2001, pp. 1109-1116
23. Gonzalez, A; Andre-Schmutz, I; Carnaud, C; Mathis, D; Benoist, C
    Damage control, rather than unresponsiveness, effected by protective DX5+Tcells in autoimmune diabetes
    NATURE IMMUNOLOGY
    
    A. Gonzalez et al., "Damage control, rather than unresponsiveness, effected by protective DX5+Tcells in autoimmune diabetes", NAT IMMUNOL, 2(12), 2001, pp. 1117-1125
24. Ohteki, T; Suzue, K; Maki, C; Ota, T; Koyasu, S
    Critical role of IL-15-IL-15R for antigen-presenting cell functions in theinnate immune response
    NATURE IMMUNOLOGY
    
    T. Ohteki et al., "Critical role of IL-15-IL-15R for antigen-presenting cell functions in theinnate immune response", NAT IMMUNOL, 2(12), 2001, pp. 1138-1143
25. Leung, RKM; Thomson, K; Gallimore, A; Jones, E; Van den Broek, M; Sierro, S; Alsheikhly, AR; McMichael, A; Rahemtulla, A
    Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment
    NATURE IMMUNOLOGY
    
    R.K.M. Leung et al., "Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment", NAT IMMUNOL, 2(12), 2001, pp. 1167-1173
26. Schaeffer, EM; Yap, GS; Lewis, CM; Czar, MJ; McVicar, DW; Cheever, AW; Sher, A; Schwartzberg, PL
    Mutation of Tec family kinase alters T helper cell differentiation
    NATURE IMMUNOLOGY
    
    E.M. Schaeffer et al., "Mutation of Tec family kinase alters T helper cell differentiation", NAT IMMUNOL, 2(12), 2001, pp. 1183-1188
27. Kishimoto, H; Sprent, J
    A defect in central tolerance in NOD mice
    NATURE IMMUNOLOGY
    
    H. Kishimoto e J. Sprent, "A defect in central tolerance in NOD mice", NAT IMMUNOL, 2(11), 2001, pp. 1025-1031
28. Biedermann, T; Zimmermann, S; Himmelrich, H; Gumy, A; Egeter, A; Sakrauski, AK; Seegmuller, I; Voigt, H; Launois, P; Levine, AD; Wagner, H; Heeg, K; Louis, JA; Rocken, M
    IL-4 instructs T(H)1 responses and resistance to Leishmania major in susceptible BALB/c mice
    NATURE IMMUNOLOGY
    
    T. Biedermann et al., "IL-4 instructs T(H)1 responses and resistance to Leishmania major in susceptible BALB/c mice", NAT IMMUNOL, 2(11), 2001, pp. 1054-1060
29. de Jong, YP; Abadia-Molina, AC; Satoskar, AR; Clarke, K; Rietdijk, ST; Faubion, WA; Mizoguchi, E; Metz, CN; Al Sahli, M; ten Hove, T; Keates, AC; Lubetsky, JB; Farrell, RJ; Michetti, P; van Deventer, SJ; Lolis, E; David, JR; Bhan, AK; Terhorst, C
    Development of chronic colitis is dependent on the cytokine MIF
    NATURE IMMUNOLOGY
    
    Y.P. de Jong et al., "Development of chronic colitis is dependent on the cytokine MIF", NAT IMMUNOL, 2(11), 2001, pp. 1061-1066
30. Bogdan, C
    Nitric oxide and the immune response
    NATURE IMMUNOLOGY
    
    C. Bogdan, "Nitric oxide and the immune response", NAT IMMUNOL, 2(10), 2001, pp. 907-916
31. Revy, P; Sospedra, M; Barbour, B; Trautmann, A
    Functional antigen-independent synapses formed between T cells and dendritic cells
    NATURE IMMUNOLOGY
    
    P. Revy et al., "Functional antigen-independent synapses formed between T cells and dendritic cells", NAT IMMUNOL, 2(10), 2001, pp. 925-931
32. Skowron, G; Street, JC; Obee, EM
    Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G. Skowron et al., "Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy", J ACQ IMM D, 28(4), 2001, pp. 313-319
33. Gerna, G; Piccinini, G; Genini, E; Percivalle, E; Zavattoni, M; Lilleri, D; Testa, L; Comolli, G; Maserati, T; Baldanti, F; Maccario, R; Monforte, AD; Revello, MG
    Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G. Gerna et al., "Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART", J ACQ IMM D, 28(4), 2001, pp. 320-331
34. Babiker, A; Darbyshire, N; Pezzotti, P; Porter, K; Rezza, G; Walker, S; Beral, V; Coutinho, R; Del Amo, J; Gill, N; Lee, C; Meyer, L; Tyrer, F; Dabis, F; Thiebaut, R; Lawson-Ayayi, S; Meyer, L; Boufassa, F; Hamouda, O; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; Aguado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Johnson, AM; Phillips, AN; Darbyshire, JH; Francioli, P; Vanhems, P; Egger, M; Rickenbach, M; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
    Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A. Babiker et al., "Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?", J ACQ IMM D, 28(2), 2001, pp. 158-165
35. Cramer, LA; Frelinger, JA
    Dendritic cells transduced with HIV Nef express normal levels of HLA-A andHLA-B Class I molecules
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    L.A. Cramer e J.A. Frelinger, "Dendritic cells transduced with HIV Nef express normal levels of HLA-A andHLA-B Class I molecules", J ACQ IMM D, 27(5), 2001, pp. 417-425
36. Huang, MB; Khan, MF; Garcia-Barrio, M; Powell, M; Bond, VC
    Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    M.B. Huang et al., "Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120", J ACQ IMM D, 27(3), 2001, pp. 213-221
37. Lucas, GM; Cheever, LW; Chaisson, RE; Moore, RD
    Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G.M. Lucas et al., "Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection", J ACQ IMM D, 27(3), 2001, pp. 251-259
38. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
    A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Ungsedhapand et al., "A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients", J ACQ IMM D, 27(2), 2001, pp. 116-123
39. Tarwater, PM; Margolick, JB; Jin, JH; Phair, JP; Detels, R; Rinaldo, C; Giorgi, J; Munoz, A
    Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P.M. Tarwater et al., "Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy", J ACQ IMM D, 27(2), 2001, pp. 168-175
40. Brambilla, AM; Castagna, A; Nocita, B; Hasson, H; Boeri, E; Veglia, F; Lazzarin, A
    Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A.M. Brambilla et al., "Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections", J ACQ IMM D, 27(1), 2001, pp. 44-48
41. Funk, GA; Fischer, M; Joos, B; Opravil, M; Gunthard, HF; Ledergerber, B; Bonhoeffer, S
    Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    G.A. Funk et al., "Quantification of in vivo replicative capacity of HIV-1 in different compartments of infected cells", J ACQ IMM D, 26(5), 2001, pp. 397-404
42. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
    Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C.A. Sabin et al., "Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine", J ACQ IMM D, 26(5), 2001, pp. 462-465
43. Girardi, E; Palmieri, F; Cingolani, A; Ammassari, A; Petrosillo, N; Gillini, L; Zinzi, D; De Luca, A; Antinori, A; Ippolito, G
    Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E. Girardi et al., "Changing clinical presentation and survival in HIV-associated tuberculosisafter highly active antiretroviral therapy", J ACQ IMM D, 26(4), 2001, pp. 326-331
44. Saha, K; Zhang, JC; Zerhouni, B
    Evidence of productively infected CD8(+) T cells in patients with AIDS: Implications for HIV-1 pathogenesis
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    K. Saha et al., "Evidence of productively infected CD8(+) T cells in patients with AIDS: Implications for HIV-1 pathogenesis", J ACQ IMM D, 26(3), 2001, pp. 199-207
45. Talal, AH; Irwin, CE; Dieterich, DT; Yee, H; Zhang, LQ
    Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A.H. Talal et al., "Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissue", J ACQ IMM D, 26(3), 2001, pp. 208-217
46. Abgrall, S; Matheron, S; Le Moing, V; Dupont, C; Costagliola, D
    Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S. Abgrall et al., "Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis", J ACQ IMM D, 26(2), 2001, pp. 151-158
47. Didier, JM; Kazatchkine, MD; Demouchy, C; Moat, C; Diagbouga, S; Sepulveda, C; Di Lonardo, AM; Weiss, L
    Comparative assessment of five alternative methods for CD4(+) T-lymphocyteenumeration for implementation in developing countries
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    J.M. Didier et al., "Comparative assessment of five alternative methods for CD4(+) T-lymphocyteenumeration for implementation in developing countries", J ACQ IMM D, 26(2), 2001, pp. 193-195
48. Talal, AH; Monard, S; Vesanen, M; Zheng, ZY; Hurley, A; Cao, YZ; Fang, F; Smiley, L; Johnson, J; Kost, R; Markowitz, MH
    Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A.H. Talal et al., "Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue", J ACQ IMM D, 26(1), 2001, pp. 1-7
49. Lafeuillade, A; Poggi, C; Chadapaud, S; Hittinger, G; Chouraqui, M; Pisapia, M; Delbeke, E
    Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    A. Lafeuillade et al., "Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission", J ACQ IMM D, 26(1), 2001, pp. 44-55
50. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
    Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S.L. Becker et al., "Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort", J ACQ IMM D, 26(1), 2001, pp. 72-81
51. Thaler, S; Schnierle, BS
    A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes
    MOLECULAR THERAPY
    
    S. Thaler e B.S. Schnierle, "A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes", MOL THER, 4(3), 2001, pp. 273-279
52. Bronte, V; Serafini, P; Apolloni, E; Zanovello, P
    Tumor-induced immune dysfunctions caused by myeloid suppressor cells
    JOURNAL OF IMMUNOTHERAPY
    
    V. Bronte et al., "Tumor-induced immune dysfunctions caused by myeloid suppressor cells", J IMMUNOTH, 24(6), 2001, pp. 431-446
53. Szabo, J; Cervenak, L; Toth, FD; Prohaszka, Z; Horvath, L; Kerekes, K; Beck, Z; Bacsi, A; Erdei, A; Peerschke, EIB; Fust, G; Ghebrehiwet, B
    Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures
    CLINICAL IMMUNOLOGY
    
    J. Szabo et al., "Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures", CLIN IMMUNO, 99(2), 2001, pp. 222-231
54. Anthony, DD; Post, AB; Valdez, H; Peterson, DL; Murphy, M; Heeger, PS
    ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis
    CLINICAL IMMUNOLOGY
    
    D.D. Anthony et al., "ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis", CLIN IMMUNO, 99(2), 2001, pp. 232-240
55. Wilhelm, M; Weissinger, F; Kunzmann, V; Muller, JG; Fahey, JL
    Idiopathic CD4(+) T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy
    CLINICAL IMMUNOLOGY
    
    M. Wilhelm et al., "Idiopathic CD4(+) T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy", CLIN IMMUNO, 99(2), 2001, pp. 298-304
56. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
    Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion
    CLINICAL IMMUNOLOGY
    
    K.D. Miller et al., "Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion", CLIN IMMUNO, 99(1), 2001, pp. 30-42
57. Ellis, TM; Le, PT; DeVries, G; Stubbs, E; Fisher, M; Bhoopalam, N
    Alterations in CD30(+) T cells in monoclonal gammopathy of undetermined significance
    CLINICAL IMMUNOLOGY
    
    T.M. Ellis et al., "Alterations in CD30(+) T cells in monoclonal gammopathy of undetermined significance", CLIN IMMUNO, 98(3), 2001, pp. 301-307
58. Newman, R; Hariharan, K; Reff, M; Anderson, DR; Braslawsky, G; Santoro, D; Hanna, N; Bugelski, PJ; Brigham-Burke, M; Crysler, C; Gagnon, RC; Dal Monte, P; Doyle, ML; Hensley, PC; Reddy, MP; Sweet, RW; Truneh, A
    Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees
    CLINICAL IMMUNOLOGY
    
    R. Newman et al., "Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees", CLIN IMMUNO, 98(2), 2001, pp. 164-174
59. Gausling, R; Trollmo, C; Hafler, DA
    Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis
    CLINICAL IMMUNOLOGY
    
    R. Gausling et al., "Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis", CLIN IMMUNO, 98(1), 2001, pp. 11-17
60. Anderson, DE; Carlos, MP; Nguyen, L; Torres, JV
    Overcoming original (antigenic) sin
    CLINICAL IMMUNOLOGY
    
    D.E. Anderson et al., "Overcoming original (antigenic) sin", CLIN IMMUNO, 101(2), 2001, pp. 152-157
61. Dyrhol-Riise, AM; Stent, G; Rosok, BI; Voltersvik, P; Olofsson, J; Asjo, B
    The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissueduring highly active antiretroviral therapy
    CLINICAL IMMUNOLOGY
    
    A.M. Dyrhol-Riise et al., "The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissueduring highly active antiretroviral therapy", CLIN IMMUNO, 101(2), 2001, pp. 169-179
62. Dyrhol-Riise, AM; Ohlsson, M; Skarstein, K; Nygaard, SJT; Olofsson, J; Jonsson, R; Asjo, B
    T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy
    CLINICAL IMMUNOLOGY
    
    A.M. Dyrhol-Riise et al., "T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy", CLIN IMMUNO, 101(2), 2001, pp. 180-191
63. Lee, SY; Huang, CK; Zhang, TF; Schofield, BH; Burks, AW; Bannon, GA; Sampson, HA; Li, XM
    Oral administration of IL-12 suppresses anaphylactic reactions in a murinemodel of peanut hypersensitivity
    CLINICAL IMMUNOLOGY
    
    S.Y. Lee et al., "Oral administration of IL-12 suppresses anaphylactic reactions in a murinemodel of peanut hypersensitivity", CLIN IMMUNO, 101(2), 2001, pp. 220-228
64. Sperling, AI
    ICOS costimulation: Is it the key to selective immunotherapy?
    CLINICAL IMMUNOLOGY
    
    A.I. Sperling, "ICOS costimulation: Is it the key to selective immunotherapy?", CLIN IMMUNO, 100(3), 2001, pp. 261-262
65. Kalinkovich, A; Borkow, G; Weisman, Z; Tsimanis, A; Stein, M; Bentwich, Z
    Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors
    CLINICAL IMMUNOLOGY
    
    A. Kalinkovich et al., "Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: Environmental and constitutive factors", CLIN IMMUNO, 100(1), 2001, pp. 107-117
66. Gomes, NA; DosReis, GA
    The dual role of CTLA-4 in Leishmania infection
    TRENDS IN PARASITOLOGY
    
    N.A. Gomes e G.A. DosReis, "The dual role of CTLA-4 in Leishmania infection", TRENDS PARA, 17(10), 2001, pp. 487-491
67. Hackstein, H; Morelli, AE; Thomson, AW
    Designer dendritic cells for tolerance induction: guided not misguided missiles
    TRENDS IN IMMUNOLOGY
    
    H. Hackstein et al., "Designer dendritic cells for tolerance induction: guided not misguided missiles", TRENDS IMMU, 22(8), 2001, pp. 437-442
68. Goldman, M; Le Moine, A; Braun, M; Flamand, V; Abramowicz, D
    A role for eosinophils in transplant rejection
    TRENDS IN IMMUNOLOGY
    
    M. Goldman et al., "A role for eosinophils in transplant rejection", TRENDS IMMU, 22(5), 2001, pp. 247-251
69. Mahlknecht, U; Herbein, G
    Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?
    TRENDS IN IMMUNOLOGY
    
    U. Mahlknecht e G. Herbein, "Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells?", TRENDS IMMU, 22(5), 2001, pp. 256-260
70. Appay, V; Rowland-Jones, SL
    RANTES: a versatile and controversial chemokine
    TRENDS IN IMMUNOLOGY
    
    V. Appay e S.L. Rowland-Jones, "RANTES: a versatile and controversial chemokine", TRENDS IMMU, 22(2), 2001, pp. 83-87
71. Montaner, LJ
    Structured treatment interruptions to control HIV-1 and limit drug exposure
    TRENDS IN IMMUNOLOGY
    
    L.J. Montaner, "Structured treatment interruptions to control HIV-1 and limit drug exposure", TRENDS IMMU, 22(2), 2001, pp. 92-96
72. Wohlleben, G; Erb, KJ
    Atopic disorders: a vaccine around the corner?
    TRENDS IN IMMUNOLOGY
    
    G. Wohlleben e K.J. Erb, "Atopic disorders: a vaccine around the corner?", TRENDS IMMU, 22(11), 2001, pp. 618-626
73. Veazey, RS; Marx, PA; Lackner, AA
    The mucosal immune system: primary target for HIV infection and AIDS
    TRENDS IN IMMUNOLOGY
    
    R.S. Veazey et al., "The mucosal immune system: primary target for HIV infection and AIDS", TRENDS IMMU, 22(11), 2001, pp. 626-633
74. Imami, N; Hardy, G; Gotch, F
    Development of immunotherapeutic strategies for HIV-1
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    N. Imami et al., "Development of immunotherapeutic strategies for HIV-1", EXPERT OP B, 1(5), 2001, pp. 803-816
75. Geyer, M; Fackler, OT; Peterlin, BM
    Structure-function relationships in HIV-1 Nef
    EMBO REPORTS
    
    M. Geyer et al., "Structure-function relationships in HIV-1 Nef", EMBO REP, 2(7), 2001, pp. 580-585
76. Schluger, NW
    Recent advances in our understanding of human host responses to tuberculosis
    RESPIRATORY RESEARCH
    
    N.W. Schluger, "Recent advances in our understanding of human host responses to tuberculosis", RESPIR RES, 2(3), 2001, pp. 157-163
77. Davis, LS; Cush, JJ; Schulze-Koops, H; Lipsky, PE
    Rheumatoid synovial CD4(+) T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells
    ARTHRITIS RESEARCH
    
    L.S. Davis et al., "Rheumatoid synovial CD4(+) T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells", ARTHRITIS R, 3(1), 2001, pp. 54-64
78. Isaacs, JD
    From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies
    RHEUMATOLOGY
    
    J.D. Isaacs, "From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies", RHEUMATOLOG, 40(7), 2001, pp. 724-738
79. Kaufmann, J; Franke, S; Kientsch-Engel, R; Oelzner, P; Hein, G; Stein, G
    Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis
    RHEUMATOLOGY
    
    J. Kaufmann et al., "Correlation of circulating interleukin 16 with proinflammatory cytokines in patients with rheumatoid arthritis", RHEUMATOLOG, 40(4), 2001, pp. 474-475
80. Gratchev, A; Schledzewski, K; Guillot, P; Goerdt, S
    Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    
    A. Gratchev et al., "Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing", SKIN PH APP, 14(5), 2001, pp. 272-279
81. Narula, S; Cuss, F
    Interleukin-10
    NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    
    S. Narula e F. Cuss, "Interleukin-10", PROG R RES, 31, 2001, pp. 269-273
82. Li, C; Dowd, CS; Zhang, W; Chaiken, IM
    Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences
    JOURNAL OF PEPTIDE RESEARCH
    
    C. Li et al., "Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences", J PEPT RES, 57(6), 2001, pp. 507-518
83. Dowd, CS; Zhang, WT; Li, CZ; Chaiken, IM
    From receptor recognition mechanisms to bioinspired mimetic antagonists inHIV-1/cell docking
    JOURNAL OF CHROMATOGRAPHY B
    
    C.S. Dowd et al., "From receptor recognition mechanisms to bioinspired mimetic antagonists inHIV-1/cell docking", J CHROMAT B, 753(2), 2001, pp. 327-335
84. Coadou, G; Evrard-Todeschi, N; Gharbi-Benarous, J; Benarous, R; Girault, JP
    Conformational analysis by NMR and molecular modelling of the 41-62 hydrophilic region of HIV-1 encoded virus protein U (Vpu). Effect of the phosphorylation on sites 52 and 56
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE II FASCICULE C-CHIMIE
    
    G. Coadou et al., "Conformational analysis by NMR and molecular modelling of the 41-62 hydrophilic region of HIV-1 encoded virus protein U (Vpu). Effect of the phosphorylation on sites 52 and 56", CR AC S IIC, 4(10), 2001, pp. 751-758
85. Turville, SG; Cameron, PU; Arthos, J; MacDonald, K; Clark, G; Hart, D; Cunningham, AL
    Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection
    JOURNAL OF CLINICAL VIROLOGY
    
    S.G. Turville et al., "Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection", J CLIN VIRO, 22(3), 2001, pp. 229-239
86. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
    Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?
    JOURNAL OF CLINICAL VIROLOGY
    
    A.M. Mijch et al., "Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?", J CLIN VIRO, 22(3), 2001, pp. 271-278
87. Pett, SL; Emery, S
    Immunomodulators as adjunctive therapy for HIV-1 infection
    JOURNAL OF CLINICAL VIROLOGY
    
    S.L. Pett e S. Emery, "Immunomodulators as adjunctive therapy for HIV-1 infection", J CLIN VIRO, 22(3), 2001, pp. 289-295
88. Garcia-Lerma, JG; Heneine, W
    Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing
    JOURNAL OF CLINICAL VIROLOGY
    
    J.G. Garcia-Lerma e W. Heneine, "Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing", J CLIN VIRO, 21(3), 2001, pp. 197-212
89. Alfano, M; Poli, G
    Cytokine and chemokine based control of HIV infection and replication
    CURRENT PHARMACEUTICAL DESIGN
    
    M. Alfano e G. Poli, "Cytokine and chemokine based control of HIV infection and replication", CUR PHARM D, 7(11), 2001, pp. 993-1013
90. Miller, MD; Hazuda, DJ
    New antiretroviral agents: looking beyond protease and reverse transcriptase
    CURRENT OPINION IN MICROBIOLOGY
    
    M.D. Miller e D.J. Hazuda, "New antiretroviral agents: looking beyond protease and reverse transcriptase", CURR OPIN M, 4(5), 2001, pp. 535-539
91. Ampel, NM; Kramer, LA; Kerekes, KM; Johnson, SM; Pappagianis, D
    Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood
    MEDICAL MYCOLOGY
    
    N.M. Ampel et al., "Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood", MED MYCOL, 39(4), 2001, pp. 315-320
92. Bondeson, J; Maini, RN
    Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM))
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    J. Bondeson e R.N. Maini, "Tumour necrosis factor as a therapeutic target in rheumatoid arthritis andother chronic inflammatory diseases: The clinical experience with infliximab (Remicade (TM))", INT J CL PR, 55(3), 2001, pp. 211-216
93. Lever, AML
    Gene therapy for HIV
    SEXUALLY TRANSMITTED INFECTIONS
    
    A.M.L. Lever, "Gene therapy for HIV", SEX TRANS I, 77(2), 2001, pp. 93-96
94. Roshal, M; Zhu, Y; Planelles, V
    Apoptosis in AIDS
    APOPTOSIS
    
    M. Roshal et al., "Apoptosis in AIDS", APOPTOSIS, 6(1-2), 2001, pp. 103-116
95. Yang, Y; Ashwell, JD
    Exploiting the apoptotic process for management of HIV: Are we there yet ?
    APOPTOSIS
    
    Y. Yang e J.D. Ashwell, "Exploiting the apoptotic process for management of HIV: Are we there yet ?", APOPTOSIS, 6(1-2), 2001, pp. 139-146
96. Lange, J
    A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm
    ANTIVIRAL THERAPY
    
    J. Lange, "A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm", ANTIVIR TH, 6, 2001, pp. 45-54
97. House, SD; Guidon, PT; Perdrizet, GA; Rewinski, M; Kyriakos, R; Bockman, RS; Mistry, T; Gallagher, PA; Hightower, LE
    Effects of heat shock, stannous chloride, and gallium nitrate on the vat inflammatory response
    CELL STRESS & CHAPERONES
    
    S.D. House et al., "Effects of heat shock, stannous chloride, and gallium nitrate on the vat inflammatory response", CELL STR CH, 6(2), 2001, pp. 164-171
98. Rausch, DM; Davis, MR
    HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases
    JOURNAL OF NEUROVIROLOGY
    
    D.M. Rausch e M.R. Davis, "HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases", J NEUROVIRO, 7(2), 2001, pp. 85-96
99. Stins, MF; Shen, Y; Huang, SH; Gilles, F; Kalra, VK; Kim, KS
    Gp120 activates children's brain endothelial cells via CD4
    JOURNAL OF NEUROVIROLOGY
    
    M.F. Stins et al., "Gp120 activates children's brain endothelial cells via CD4", J NEUROVIRO, 7(2), 2001, pp. 125-134
100. Shieh, TM; Carter, DL; Blosser, RL; Mankowski, JL; Zink, MC; Clements, JE
     Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus
     JOURNAL OF NEUROVIROLOGY
     
     T.M. Shieh et al., "Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus", J NEUROVIRO, 7(1), 2001, pp. 11-24